Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $1.6M invested in Pacer BioThreat Strategy ETF in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
3% more capital invested
Capital invested by funds: $1.55M → $1.6M (+$51.7K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$572K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$83.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$18.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$658K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$82.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $660K | +$83.7K | +2,780 | +16% |
|
|
IAIM
2
International Assets Investment Management
Orlando,
Florida
| $614K | +$572K | +18,989 | New |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $304K | -$82.3K | -2,735 | -23% |
|
|
4
UBS Group
Zurich,
Switzerland
| $26.2K | +$18.4K | +610 | +305% |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$658K | -22,059 | Closed |
|
VIRS Hedge Fund Activity: Q4 2023 in Review
4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q4 2023, worth a combined $1.6M — up 3.3% from $1.55M a quarter earlier.
Fund positioning in VIRS was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was International Assets Investment Management, opening a new position worth an estimated $572K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $658K sold.
- 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $1.6M of Pacer BioThreat Strategy ETF stock for Q4 2023, up 3.3% quarter-over-quarter.
- 1 fund opened new Pacer BioThreat Strategy ETF positions in Q4 2023 and 1 closed out, a net change of 0 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q4 2023 was International Assets Investment Management, an estimated $572K added.
- The largest Pacer BioThreat Strategy ETF seller in Q4 2023 was Royal Bank of Canada, an estimated $658K sold.
Based on aggregated 13F filings for Q4 2023.